By Justin Petrone

Agilent Technologies last week reported first-quarter revenue growth of 4 percent, led by double-digit growth in its Life Sciences and Chemical Analysis segments.

The Santa Clara, Calif.-based firm brought in total revenues of $1.21 billion for the three-month period ended Jan. 31, 2010, the first quarter of its fiscal year, compared to revenues of $1.17 billion for the first quarter of 2009. Agilent beat analysts' consensus estimate for revenues of $1.18 billion for the quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.